#1889 Global Rank Marché Ouvert

Robert Langer

Santé & Biotech. Biotech.

Fortune Nette (Est.)

$2.2 B
+$18 (+0.00%) Aujourd'hui
Portefeuille : Korro Bio ▲ High Growth Lyra Therapeutics ▲ High Growth Moderna, Inc. ▲ High Growth Seer ▲ High Growth
Robert Langer

Photo: Press Agency / 2026

Profil Financier

Robert Langer occupe actuellement le rang #1889 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.2 B (+$18 sur 24h).

Robert Langer is a scientist and professor at the Massachusetts Institute of Technology, where he leads the eponymous Langer Lab.

Langer was a founder of Cambridge, Mass.-based biotech firm Moderna; he owns a 3% stake in the company and has never sold a share.

He has also held stakes in SQZ Biotechnologies, Seer and Sigilon Therapeutics, which were founded by him and postdoc students from his lab.

Langer is estimated to be the most cited engineer in history, with more than 415,000 citations and more than 1,500 articles published.

He also holds more than 1,400 patents and patent applications, which have been licensed more than 400 times to biotech and pharma companies.

Langer has received more than 200 prizes throughout his career, including the National Medals of Science and Technology.

He has been dubbed the "Edison of Medicine" for his work in biomedical engineering.

Historique de Fortune (12 Mois)

1A 5A Max
Jan 25 Juin 25 Déc 25 Auj.

Répartition des Actifs

Actif / Société Parts Détenues Valeur Est. Tendance
Korro Bio (KRRO) - $0 High Growth
Lyra Therapeutics (LYRA) 303 parts $45 High Growth
Moderna, Inc. (MRNA) 11.5M parts $2.2 B High Growth
Seer (SEER) 18.7K parts $42,055 High Growth
Seer (SEER) 725.8K parts $2 M High Growth